Inventor

JACOBSEN JOHN R

US69 patents

⚠️ This page may combine multiple inventors who share the name “JACOBSEN JOHN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JACOBSEN JOHN R

THERAVANCE INC

Aryl aniline β2 adrenergic receptor agonists

Aryl aniline β2 adrenergic receptor agonists

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Aryl aniline β2 adrenergic receptor agonists

Aryl aniline β2 adrenergic receptor agonists

Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Amino-substituted ethylamino β2 adrenergic receptor agonists

Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Local anesthetic compounds and uses

Aryl aniline β2 adrenergic receptor agonists

Local anesthetic compounds and uses

THERAVANCE BIOPHARMA R&D IP LLC

JAK kinase inhibitor compounds for treatment of respiratory disease

JAK kinase inhibitor compounds for treatment of respiratory disease

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

JAK kinase inhibitor compounds for treatment of respiratory disease

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

JAK kinase inhibitor compounds for treatment of respiratory disease

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

JAK kinase inhibitor compounds for treatment of respiratory disease

LONG DANIEL D

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

THERAVANCE RESPIRATORY CO LLC

Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity

3M INNOVATIVE PROPERTIES CO

Ether substituted imidazopyridines

Ether substituted imidazopyridines

Ether substituted imidazopyridines

Acrylic adhesive composition with controlled molecular weight

Adhesive composition

HUGHES ADAM D

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

ADVANCED MEDICINE INC

Local anesthetic compounds

Local anesthetic compounds and uses

LEADBETTER MICHAEL R

Aminotetralin compounds as mu opioid receptor antagonists

Aminotetralin compounds as mu opioid receptor antagonists

DICE ALPHA INC

Substituted benzenecarboxamides as IL-17A modulators

Substituted benzenecarboxamides as IL-17A modulators

HUGHES ADAM

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

SAITO DAISUKE ROLAND

Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

TRAPP SEAN G

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

SATRIJO ANDREW

Hot melt processable pressure sensitive adhesives containing fibrous materials